Correlation Between Clinical Deterioration in Schizophrenic Patients and Hair Cortisol Levels
NCT01754532 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 34
Last updated 2018-04-20
Summary
The importance of stress as a possible deteriorating factor for schizophrenic patients is well documented. However, this notion is based on subjective experience and retrospective psychological analysis.
A novel method of measuring cortisol using hair has a proven correlation to subjective stress in non-clinical as well as psychiatric clinical populations.
This pilot study will attempt to assess the use of cortisol hair level, as a marker of stress, to predict clinical deterioration in schizophrenic patients.
Conditions
- Schizophrenia
- Schizo-Affective Disorder
Interventions
- BIOLOGICAL
-
Hair Sample
Analysis of hair cortisol levels
Sponsors & Collaborators
-
Shalvata Mental Health Center
lead OTHER
Principal Investigators
-
Aviv Segev, MD · Shalvata MHC
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-01-31
- Primary Completion
- 2015-06-30
- Completion
- 2016-01-31
Countries
- Israel
Study Locations
More Related Trials
-
Investigation of Neurophysiological Markers, Possibly Specific of Two Subforms of Psychotic Disorders
NCT03649581 ·Status: RECRUITING ·Phase: NA
-
Open-label Study of Curcumin C-3 Complex in Schizophrenia
NCT01875822 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Assessment of Schizophrenia Patients' Clinical Study Experiences
NCT05948111 ·Status: NOT_YET_RECRUITING
-
Pregnenolone in the Management of Schizophrenia Patients
NCT00174889 ·Status: COMPLETED ·Phase: PHASE1
-
Vitamin D for Schizophrenia
NCT01759485 ·Status: COMPLETED ·Phase: NA
-
D-cycloserine Augmentation of Cognitive Remediation in Schizophrenia
NCT00963924 ·Status: COMPLETED ·Phase: NA
-
Prolactin Change in Chinese Patients With Schizophrenia After Antipsychotics Treatment
NCT04002258 ·Status: COMPLETED
-
Exploratory Cognition Study of Sertindole in Patients With Schizophrenia
NCT00759421 ·Status: COMPLETED ·Phase: PHASE3
-
Measuring the Effect of Remote Monitoring of Treatment Adherence on the Risk of Re-admission of Ambulatory Schizophrenic Patients
NCT01729572 ·Status: UNKNOWN ·Phase: NA
-
What the Nose Knows: Hedonic Capacity, Psychosocial Interventions and Outcomes in Schizophrenia
NCT05282186 ·Status: COMPLETED ·Phase: NA
-
High Dose D-Serine as Adjuvant Treatment for Recent Onset Schizophrenia
NCT01459029 ·Status: UNKNOWN ·Phase: PHASE2
-
Linear and Non-linear Analysis of EEG Changes in Schizophrenia After Atypical Antipsychotics Medication
NCT00698295 ·Status: UNKNOWN
-
Trial of D-Cycloserine in Schizophrenia
NCT00000371 ·Status: COMPLETED ·Phase: PHASE3
-
Neuroendocrine and Immune Response to Stress in Schizophrenia
NCT01975584 ·Status: COMPLETED ·Phase: NA
-
Treatment With Acamprosate in Patients With Schizophrenia and Comorbid Alcoholism
NCT00463346 ·Status: COMPLETED ·Phase: PHASE3
-
Studies of Frontal Lobe Brain Functioning in Schizophrenia
NCT00001258 ·Status: COMPLETED
-
A Neurobiological Study on Heterogeneity of Schizophrenia: Genetic Variations and Neurobiological Differentiations
NCT01075373 ·Status: UNKNOWN
-
Evaluation of the Role of Neurodegeneration in Schizophrenia
NCT05257720 ·Status: COMPLETED
-
Shiatsu Adjuvant Therapy For Schizophrenia
NCT00425399 ·Status: COMPLETED ·Phase: NA
-
Factors Association With Poor Physical Function in Older Adults With Schizophrenia
NCT01092598 ·Status: COMPLETED
-
Trial to Study the Effect of CVL-231 on 24-Hour Ambulatory Blood Pressure in Participants With Schizophrenia
NCT05245539 ·Status: COMPLETED ·Phase: PHASE1
-
Using D-cycloserine to Enhance the Benefits of Cognitive Behavioral Therapy for Schizophrenia
NCT00742079 ·Status: COMPLETED ·Phase: PHASE4
-
Modafinil Augmentation Therapy for Excessive Daytime Sleepiness and Negative Symptoms in Patients With Schizophrenia
NCT00546403 ·Status: COMPLETED ·Phase: NA
-
Changes in Brain Synchronization During Perceptual and Linguistic Tasks in Schizophrenic Patients
NCT01550211 ·Status: UNKNOWN
-
Clozapine Versus Chlorpromazine for Treatment-Unresponsive Schizophrenia
NCT00169039 ·Status: TERMINATED ·Phase: PHASE4